Please try another search
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company’s drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas.
Name | Age | Since | Title |
---|---|---|---|
Anthony J. Hickey | - | 2022 | Chairman of the Scientific Advisory Board and Senior Research & Development Advisor |
David N. Cornfield | - | 2021 | Member of Scientific Advisory Board |
Stephen Charles Rocamboli | 51 | 2018 | Independent Director |
Ted M. Ross | - | 2021 | Member of Scientific Advisory Board |
Drew Weissman | - | 2021 | Member of Scientific Advisory Board |
Mike Saag | - | 2021 | Member of Scientific Advisory Board |
Robert S. Mills | 70 | 2018 | Independent Director |
Harlan F. Weisman | 71 | 2018 | President, CEO & Director |
Jay Peters | - | 2021 | Member of Scientific Advisory Board |
David W. Denning | - | 2021 | Member of Scientific Advisory Board |
Brandi L. Roberts | 49 | 2022 | Independent Director |
Michael A. Patane | 59 | 2023 | Independent Director |
Thomas B. King | 69 | 2023 | Independent Director |
Catherine C. Lee | 50 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review